Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
- Francisco J. Esteva
- , Carol D. Cheli
- , Herbert Fritsche
- , Monica Fornier
- , Dennis Slamon
- , Robert P. Thiel
- , Diana Luftner
- , Farooq Ghani
Research output: Contribution to journal › Article › peer-review
141
Citations
(Scopus)